Strong Clinical Expertise Quartesian has over a decade of specialized experience in clinical data services, including statistical programming, data management, and study design, making it a valuable partner for biopharmaceutical and medical device companies seeking reliable trial support.

Strategic Industry Partnerships The company's recent collaborations with Amyndas Pharmaceuticals and a multi-year agreement with Medrio highlight its ability to integrate advanced eClinical technologies and expand service offerings, presenting opportunities to upsell or develop joint solutions.

Recent Private Equity Acquisition The acquisition by Summit Partners in June 2021 indicates strong investor confidence and potential for growth, which can translate into increased marketing and business development resources to expand client reach.

Growth Potential With a revenue range of 10 to 25 million dollars and an experienced team, Quartesian is positioned to scale its clinical data services, especially in niche areas such as COVID-19 trial support, creating opportunities in emerging therapeutic areas.

Technology Integration Utilizing advanced tools like AWS, Medrio, and Medidata, Quartesian emphasizes modern, tech-driven solutions, which can appeal to clients looking for innovative, data-centric clinical trial partnerships.